Clinical Trial Update: A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial investigating the safety and efficacy of fluvastatin in genotype 1 hepatitis C patients who previously partially responded to pegylated in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Fluvastatin (fluvastatin)

Snippet

Sponsor: University of Chicago | Conditions: Hepatitis C, Hepatitis C Virus | Phase 2 | Status: WITHDRAWN